Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 24;15(11):2342.
doi: 10.3390/ijerph15112342.

Summary Outcomes of the ODIN Project on Food Fortification for Vitamin D Deficiency Prevention

Affiliations
Review

Summary Outcomes of the ODIN Project on Food Fortification for Vitamin D Deficiency Prevention

Mairead Kiely et al. Int J Environ Res Public Health. .

Abstract

Food-based solutions for optimal vitamin D nutrition and health through the life cycle (ODIN) was a cross-disciplinary, collaborative project, including 30 partners from 19 countries, which aimed to develop evidence-based solutions to prevent low vitamin D status (25-hydroxyvitamin D (25(OH)D) < 30 nmol/L) using a food-first approach. This paper provides a summary overview of some of the important ODIN outcomes and outlines some outstanding data requirements. In a study of almost 56,000 individuals, the first internationally standardised dataset of vitamin D status showed that 13% of EU residents overall, across a latitude gradient of 35° N to 69° N, had serum 25(OH)D < 30 nmol/L and 40% were < 50 nmol/L. The risk of low vitamin D status was several-fold higher among persons of ethnic minority. However, additional data from quality bio-banked sera would be required to improve these estimates. To address the question of dietary requirements for vitamin D among under-researched life-stage and population groups, four dose-response RCTs conducted in Northern Europe showed that vitamin D₃ intakes of 8 and 13 μg/day prevented 25(OH)D decreasing below 30 nmol/L in white children and adolescents and 20 and 30 μg/day, respectively, achieved ≥50 nmol/L. Among white women during pregnancy, 30 μg/day is required to prevent umbilical cord 25(OH)D, representing new-born vitamin D status, below 25 nmol/L. While 8 μg/day protected white women in Finland at the 30 nmol/L cut-off, 18 μg/day was needed by women of East African descent to prevent 25(OH)D decreasing below 30 nmol/L during wintertime. Replicate RCTs are needed in young children <5 years and in school-age children, teens and pregnant women of ethnic minority. Using a series of food production studies, food-based RCTs and dietary modelling experiments, ODIN research shows that diverse fortification strategies could safely increase population intakes and prevent low vitamin D status. Building on this solid technological platform, implementation research is now warranted to scale up interventions in real-world settings to eradicate vitamin D deficiency.

Keywords: 25-hydroxyvitamin D; bio-fortification; dietary modelling; dietary requirements; food fortification; vitamin D.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funder had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Prevalence of vitamin D deficiency (serum 25(OH)D < 30 nmol//L) in European young and adult/older adult, populations (adapted from Cashman et al [14]).

References

    1. Autier P., Mullie P., Macacu A., Dragomir M., Boniol M., Coppens K., Pizot C., Boniol M. Effect of vitamin D supplementation on non-skeletal disorders: A systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5:986–1004. doi: 10.1016/S2213-8587(17)30357-1. - DOI - PubMed
    1. Ebeling P., Adler R., Jones G., Liberman U.A., Mazziotti G., Minisola S., Munns C., Napoli N., Pittas A., Giustina A., et al. Management of endocrine disease: Therapeutics of vitamin D. Eur. J. Endocrinol. 2018;179:R239–R259. doi: 10.1530/EJE-18-0151. - DOI - PubMed
    1. Manson J.E., Bassuk S.S., Lee I.M., Cook N.R., Albert M.A., Gordon D., Zaharris E., Macfadyen J.G., Danielson E., Lin J., et al. The vitamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp. Clin. Trials. 2012;33:159–171. doi: 10.1016/j.cct.2011.09.009. - DOI - PMC - PubMed
    1. Pradhan A.D., Manson J.E. Update on the vitamin D and OmegA-3 trial (VITAL) J. Steroid Biochem. Mol. Biol. 2016;155:252–256. doi: 10.1016/j.jsbmb.2015.04.006. - DOI - PMC - PubMed
    1. Institute of Medicine . In: Dietary Reference Intakes for Calcium and Vitamin D. Ross A.C., Taylor C.L., Yaktine A.L., Del Valle H.B., editors. National Academies Press; Washington, DC, USA: 2011. - PubMed

Publication types